Login / Signup

Concurrent versus sequential or no triazole anti-fungal therapy in patients undergoing 7 + 3 plus midostaurin induction for FLT-3 acute myelogenous leukemia.

Dat NgoJose TinajeroJianying ZhangAnthony SteinGuido MarcucciAmandeep SalhotraVinod PullarkatKaramjeet S SandhuBrian J BallHoda PourhassanPaul Koller
Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Azoles given concurrently or sequentially with midostaurin were found to be equally safe and effective in the treatment of newly diagnosed FLT3 AML. Additional confirmatory studies are needed due to our limited sample size.
Keyphrases